Analystreport

NeoGenomics (NASDAQ:NEO) had its "overweight" rating reaffirmed by analysts at Piper Sandler.

NeoGenomics, Inc.  (NEO) 
Last neogenomics, inc. earnings: 4/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.neogenomics.com